Current report 39/2021 – Conditional registration of the Company’s D-series shares with the KDPW

Date prepared: 09/16/2021                                                                                                               

Abbreviated name of the issuer: CELON PHARMA S.A.

Subject: Conditional registration of the Company's D-series shares with the Central Securities Depository of Poland (KDPW)                                                         

Legal basis: Article 56 subs. 1 point 2 of the Act on Public Offering – current and periodical information

Content of the report:                                                                                                                                

The Management Board of Celon Pharma S.A. (the “Company”) hereby informs about the statement of the Central Securities Depository of Poland (Krajowy Depozyt Papierów Wartościowych S.A. (“KDPW”), issued on 14 September 2021, on conditional registration in the depository of securities, under ISIN PLCLNPH00015 code; 6,000,000 ordinary D-series bearer shares of the Company with a nominal value of PLN 0.10 each. The registration of D-series shares is conditional upon their introduction to trading on the regulated market on which other shares of the Company bearing the aforementioned ISIN code have been introduced. D-series shares will be registered within 3 days of KDPW’s receipt of a decision to introduce the above-mentioned shares to trading on the regulated market, however not earlier than on the date indicated in that decision as the date of introduction of the above-mentioned shares to trading